VDR Gene Polymorphisms and Weight Loss in Non-diabetic Overweight and Obese Subjects
The Influence of Vitamin D Receptor (VDR) Gene Polymorphisms (BsmI, TaqI, ApaI, FokI) on Weight Loss by Diet and Exercise Interventions in Non-diabetic Overweight and Obese Subjects
1 other identifier
interventional
110
1 country
1
Brief Summary
This is a six months intervention study in non-diabetic overweight and obese subjects. Subjects will be counseled for weight loss through diet and exercise. Diet and exercise will be recommended as per the regular norms for weight loss (weight loss ≥10% from baseline weight will be considered as a significant loss of weight) for overweight and obese subjects. A sample size of 90 subjects was calculated but assuming a drop out rate of 20%, 110 subjects will be enrolled. Enrolled subjects will be measured at every visit (monthly) for weight, body composition measures of abdominal obesity and skin folds. They would be assessed for compliance with diet and exercise. Detailed analysis of body composition including DXA, biochemical analysis will be performed at enrollment and after six months intervention. Statistical analysis will be performed to find association between measures of body composition for weight loss and genotypes of the VDR polymorphisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2016
CompletedFirst Submitted
Initial submission to the registry
July 26, 2017
CompletedFirst Posted
Study publicly available on registry
December 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2019
CompletedFebruary 4, 2021
February 1, 2019
3 years
July 26, 2017
February 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Body weight (Kg)
weight loss
6 months
Secondary Outcomes (1)
Genetic polymorphism
6 months
Study Arms (1)
Diet and Exercise
OTHERInterventions
Eligibility Criteria
You may qualify if:
- yrs
- BMI ≥ 23 kg/m2
You may not qualify if:
- Type 1 or Type 2 Diabetes.
- On drugs or meal supplements for weight loss.
- On calcium and or vitamin D supplement currently or in the previous six months.
- Have past or current history or family history of renal stones.
- Have participated in any other investigational drug study in the previous three months.
- Have any systemic diseases (cardiac, hepatic, endocrine or renal) or taking any kind of treatment more than one month in the last six months.
- Diagnosed malabsorption (celiac disease, Cohn's, ulcerative colitis) or history suggestive of malabsorption.
- Have past history of bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diabetes Foundation, Indialead
- Indian Council of Medical Researchcollaborator
Study Sites (1)
Anoop misra
New Delhi, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
July 26, 2017
First Posted
December 29, 2017
Study Start
March 16, 2016
Primary Completion
March 30, 2019
Study Completion
March 30, 2019
Last Updated
February 4, 2021
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share